A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes
New research shows sotagliflozin is the only drug in its class to demonstrate these results.
New research shows sotagliflozin is the only drug in its class to demonstrate these results.
What's Your Reaction?
